Beth Marsh will lead commercialization for Neurotech, which gained FDA approval for its eye disease therapy. Neurotech in May ...

A vow by the agency’s new commissioner, Marty Makary, to support innovation might ease fears stoked by Health and Human ...

The global marketplace is here to stay. But global competition must take place on fair, transparent and enforceable terms, ...

Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the impact of mass layoffs at the FDA, impact on ...

Third Harmonic Bio is going to shut down, should shareholders accept a plan by directors to liquidate the San Francisco ...

Find out how you can mitigate risks when expanding your biotech business internationally in the current tariff and trade ...

Biotech was starting to show signs of recovery after years of investor pullback—until new tariffs and economic uncertainty ...

Ascletis is taking a low and slow approach to oral GLP-1 dose titration in a phase 2a test after getting a look at clinical ...

Roche’s Genentech has inked a deal with Repertoire Immune Medicines aimed at discovering and developing T-cell-targeted ...

Zurich-based startup Veraxa Biotech has reached a deal to merge with special purpose acquisition company (SPAC) Voyager, ...

Thermo Fisher Scientific reported better-than-expected profit and revenue for the first quarter on Wednesday, helped by ...

Biotech entrepreneur Sam Waksal has been accused of "reckless conduct," including using a veterinary medicine on a severely ...